tooluniverse-clinical-trial-design

Warn

Audited by Snyk on Mar 29, 2026

Risk Level: MEDIUM
Full Analysis

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

  • Third-party content exposure detected (high risk: 1.00). The skill's mandatory workflow (SKILL.md "Tool Reference by Research Path" and STUDY_DESIGN_PROCEDURES.md / WORKFLOW_DETAILS.md) requires calling and ingesting open/public third‑party sources such as PubMed_search_articles, search_clinical_trials (ClinicalTrials.gov), OpenTargets, ClinVar/COSMIC/gnomAD, FAERS, DrugBank and OpenFDA, and the agent must read and synthesize those untrusted, user‑generated/public data to drive feasibility scores and design decisions—so external content can materially influence actions.

Issues (1)

W011
MEDIUM

Third-party content exposure detected (indirect prompt injection risk).

Audit Metadata
Risk Level
MEDIUM
Analyzed
Mar 29, 2026, 11:31 PM
Issues
1